Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Evidence released in the Lancet demonstrates a link between patient age and risk of revision on knee and hip replacements.

Researchers at NDORMS, University of Oxford have examined data from over 100,000 patients who have previously undergone joint replacements to enable prediction of the likelihood of requiring surgical revision of the joint.

There are an increasing number of patients undergoing total knee and hip joint replacements every year. These have proven beneficial to patients, but with replacement comes the risk that the joint might require subsequent surgical revision which, in turn, can lead to less favourable outcomes.

Their study has shown that while the lifetime risk of joints requiring revision is around 5% in patients who receive joint replacements at aged 70 or above, for men in their early fifties this can rise to over a third. Presenting risk information in this way can allow patients, particularly younger patients, to make more informed decisions about if and when to opt for joint replacement surgery.

Lead Investigator Professor Andrew Price, Prof of Musculoskeletal Sciences at NDORMS confirmed "This work is of great importance for all patients who are considering whether to undergo a joint replacement. It is critical that they have the best information available to make informed decisions and we believe this work is a significant contribution to achieve this goal".

To read the full paper entitled "The effect of Patient Age at Intervention on Risk of Implant Revision after Total Replacement of the Hip or Knee: A population=based cohort study" can be read here.

Similar stories

Plaster cast or metal pins to treat a broken wrist? The results are in.

An Oxford study published in The BMJ has found the use of metal K-wires (commonly known as ‘pins’) to hold broken wrist bones in place while they heal are no better than a traditional moulded plaster cast.

Professor Chris Buckley has joined the Kennedy Institute as Director of Clinical Research

Moving to the University of Oxford with the Arthritis Therapy Acceleration Programme (A-TAP) will help accelerate the discovery of new treatments for inflammatory diseases.

Behind enemy lines: research finds a new ally in the fight against cardiovascular disease hidden within the vessel wall itself

A new study reveals the existence of a powerful ally in the fight against cardiovascular disease, a protective subset of vascular macrophages expressing the C-type lectin receptor CLEC4A2, a molecule which fosters “good” macrophage behaviour within the vessel wall.

More effective treatment found for patients hospitalised with COVID-19 pneumonia

A proof-of-concept trial involving Oxford researchers has identified a drug that may benefit some patients hospitalised with COVID-19 pneumonia.

NDORMS researchers honoured in the Recognition Of Distinction Scheme 2021

Sally Hopewell and John Christianson have been awarded the title of ‘Full Professor’ in the University of Oxford’s Recognition Of Distinction Scheme 2021.

New Oxford-Zeiss Centre of Excellence opens at the University of Oxford

The Kennedy Institute for Rheumatology and the Institute of Developmental and Regenerative Medicine announce the launch of the Oxford-Zeiss Centre of Excellence, providing state-of-the-art imaging technologies to lead future discoveries in global health and disease.